Chinese Expert Consensus for the Management of Thrombocytopenia in Cirrhosis
Thrombocytopenia in cirrhosis presents significant challenges in clinical practice. To help clinicians rapidly understand and standardize the diagnosis and treatment of this condition, the Liver Fibrosis, Cirrhosis, and Portal Hypertension Group under the Chinese Society of Hepatology, Chinese Medical Association, convened experts across relevant fields to formulate the <i>Expert Consensus for the Management of Thrombocytopenia in Cirrhosis</i>. This consensus aimed to provide evidence-based guidance for clinical diagnosis and treatment.
Authors
- Jidong Jia (ORCID: https://orcid.org/0000-0002-4673-8890)
- Jinghang Xu
- Lai Wei (ORCID: https://orcid.org/0000-0001-7519-627X)
- Xiaoyuan Xu (ORCID: https://orcid.org/0000-0002-1759-4330)
- Zhongping Duan (ORCID: https://orcid.org/0000-0002-2188-9692)
- Yang Song (ORCID: https://orcid.org/0000-0002-1714-5527)
- Yifan Han (ORCID: https://orcid.org/0000-0002-5833-069X)
- Yuemin Nan (ORCID: https://orcid.org/0000-0003-4192-099X)
- Yujuan Guan (ORCID: https://orcid.org/0000-0001-6499-599X)
- Hui Zhuang
Institutions
- Hebei Medical University (CN)
- Capital Medical University (CN)
- Peking University (CN)
- Third Hospital of Hebei Medical University (CN)
- Peking University First Hospital (CN)
- Beijing YouAn Hospital (CN)
- Beijing Friendship Hospital (CN)
- Beijing Ditan Hospital (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Guangzhou Eighth People's Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Clinical and Translational Hepatology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.14218/jcth.2025.00105
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00